Introduction
Intrauterine insemination (IUI) has been widely used as a common treatment for infertile couples. The reported clinical pregnancy rate varies considerably, ranging from 5 to 20%. [1] [2] [3] [4] Although an encouraging clinical pregnancy rate (12-18%) has been reported, [5] [6] [7] [8] the application of IUI in modern infertility practice has recently been questioned.
The UK National Institute for Health and Care Excellence (NICE) guideline suggests that IUI is of limited value for people with unexplained infertility, mild endometriosis or 'mild male factor infertility'. 9 IUI is considered a first-line procedure among assisted reproductive techniques due to its simplicity, ease of management, relatively low incidence of complications and low cost. However, when IUI is used, should ovarian stimulation be used at the same time? Some investigators have advocated using the natural cycle 10, 11 whereas others have claimed that ovarian stimulation may lead to better results. 12, 13 Furthermore, there is still no consensus on the optimal protocol for ovarian stimulation. Various stimulation protocols have been applied, including clomifene citrate (CC), letrozole (LE), human menopausal gonadotrophin (HMG), urinary follicle-stimulating hormone (uFSH), recombinant FSH (rFSH) and combinations of these products. In this retrospective study we analysed the outcomes of 8893 cycles of IUI treatment with different protocols for ovarian stimulation and compared the risk of multiple pregnancy and ovarian hyperstimulation syndrome (OHSS) among various protocols.
Methods

Patients
This was a retrospective study using data accumulated over a 7-year period between 2006 and 2012 inclusive. A total of 5109 couples who underwent IUI treatment in our centre were included. The clinical details and outcome of treatment were retrieved from our clinical database. The inclusion criteria for IUI included: infertility for at least 1 year, at least one patent fallopian tube and absence of a severe male factor. Women were excluded if there was evidence of premature ovarian failure. This study was approved by the local hospital ethics committee.
Ovarian stimulation and follicle monitoring
This study used five types of ovarian stimulation protocol: 1 CC 50 mg/day starting from days 3-5 for 5 days. 2 LE 2.5 mg/day from days 3-5 for 5 days. 3 HMG 75 IU/day starting from days 3-5 for a variable duration depending on the response. 4 CC combined with HMG -CC 50 mg/day starting from days 3-5 for 5 days followed by the addition of 75 IU of HMG for a variable duration depending on the response. 5 LE combined with HMG -LE 2.5 mg/day starting from days 3-5 for 5 days followed by the addition of 75 IU of HMG for a variable duration depending on the response.
In all treatment cycles, whether natural or stimulated, a serial follicle scan was performed starting from day 11 or 12 of the cycle. We did not routinely perform any hormone monitoring. When at least one mature follicle had a diameter of 18 mm or more we triggered ovulation with intramuscular injection of urinary human chorionic gonadotrophin (hCG) (5000-10 000 IU) (Livzon, Zhuhai, China). Insemination was performed 36-40 hours after injection of hCG. We cancelled the IUI treatment cycle when there were more than three mature follicles.
Semen preparation and insemination
Semen was collected by masturbation after abstinence for 3-7 days and prepared with two-layer density gradient centrifugation after liquefaction. Only one insemination procedure was performed in each treatment cycle. The volume of washed semen sample used for insemination 0.3-0.5 ml.
Luteal support and follow-up
The luteal phase was used routinely in all patients, commencing the day after IUI. It consisted of microniSed progesterone (Dydrogesterone Tablets, 20mg/day, Abbott, Chicago, U.S.A) for 13 days. A blood sample was obtained 14 days after insemination for hCG assay to confirm whether pregnancy had occurred. In women with positive hCG, ultrasound examination was performed at 7 weeks' gestation to confirm fetal viability. A clinical pregnancy was defined as one in which there was ultrasonographic evidence of an intrauterine insemination gestational sac.
Statistical analysis SPSS 16.0 software was used for data analysis. A chi-square test was used to compare categorical data between groups. Student's t-test was used to compare continuous variables between groups. A P-value <0.05 was considered statistically significant.
Results
A total of 8893 cycles of IUI treatment were included; 2591 of these in natural cycles and 6302 in stimulated cycles. Patient demographics are presented in Table 1 . The mean age, body mass index (BMI), antral follicle count (AFC) and duration of infertility were not significantly different among natural and stimulated cycles (P > 0.05); the mean number of dominant follicles in stimulated cycles was 1.68 AE 0.81. In the past 6 years, the pregnancy rate in our centre for IUI with a natural cycle did not vary significantly year by year (8.3, 9.7, 10.4, 8.1, 9.4 and 8.7%, respectively; P = 0.52). No triplet pregnancies or OHSS were observed in stimulated cycles.
The live birth and pregnancy rates of ovulatory women undergoing IUI treatment in a natural cycle were 7.6 and 9.3%, respectively. The results of IUI using the different protocols of ovarian stimulation are summarised in Table 2a . Only ovarian stimulation with LE combined with HMG produced a significantly higher live birth and clinical pregnancy rates (12.2 and 16.8%, respectively). The results of other forms of stimulation were not significantly different from those with natural cycles. HMG stimulation (all three groups combined) was associated with a significantly higher twin pregnancy rate (14/189, 7.4%) than no stimulation (0%) (P < 0.001). We also observed that the live birth rate appeared to be lower in those stimulated with CC (6.1%) and LE (5.0%) compared with no stimulation (7.6%) (P = 0.05 and 0.14, respectively).
The live birth and pregnancy rates achieved in anovulatory women with the different protocols of ovarian stimulation are compared in Table 2b . The live birth rate was the lowest with LE (5.1%) and the highest with combined LE and HMG (13.6%). But contingency table analysis showed no statistical difference among the groups. When we combined all types of stimulation together, the pregnancy rate in anovulatory women was 16%, significantly higher than that of ovulatory women without stimulation (9.3%) (P < 0.01). Figure 1 compares the outcomes of IUI in ovulatory and anovulatory women for each ovarian stimulation protocol. The live birth and pregnancy rates achieved in anovulatory women were consistently higher than in ovu- latory women. Statistical significance (P < 0.01) was achieved in CC and CC combined with HMG but not for other forms of stimulation.
Discussion
Main findings
Our study found that in ovulatory women undergoing IUI, ovarian stimulation with CC, LE, HMG, or CC combined with HMG did not improve the pregnancy or live birth rates but stimulation with LE combined with HMG significantly increased these rates. On the other hand, in anovulatory women undergoing ovarian stimulation and IUI, different protocols did not affect the outcomes, although LE on its own seemed to have the lowest pregnancy and live birth rates, whereas LE combined with HMG appeared to have the highest pregnancy and live birth rates.
Strengths and limitations
Our study represents the largest ever reported series of cases on IUI treatment from a single centre. We have also analysed separately the results for women with or without an ovulatory disorder and found that ovarian stimulation had different impacts on these two groups of women. The limitation, however, is the retrospective nature of our study with its potential, inherent bias. The conclusion should therefore be considered tentative pending confirmation from randomised controlled trials. 
Interpretation
It remains controversial whether ovarian stimulation improved the outcome of IUI treatment in ovulatory women. Some investigators have suggested a beneficial effect, 12, 14 whereas others observed no benefit. 11 In some cases, the protocols of ovarian stimulation were clearly defined, 12, 15 but in others, different protocols were grouped together. 13, 14 In our study when all ovarian stimulation protocols were lumped together, we could not find any difference in pregnancy or live birth rate. The same applied to our case series if we grouped all cases of ovarian stimulation together, in which case the live birth and pregnancy rates were 7 and 9.5% compared with no stimulation, for which the corresponding rates were 7.6 and 9.3% (P = 0.39 and 0.77, respectively). However, a further analysis of the impact of the different types of ovarian stimulation showed that whereas stimulation with CC, LE, HMG or CC combined with HMG did not improve the outcome, stimulation with LE combined with HMG did significantly increase the pregnancy and live birth rates.
LE causes androgens to accumulate in the ovarian follicles by blocking the conversion of androgens to estrogens. The accumulated androgens may increase the sensitivity of the growing follicles to FSH by increasing the expression of FSH receptors; 16 this may explain the special advantage of combining LE with HMG in ovarian stimulation.
Our study is consistent with earlier reports with regard to the lack of benefit of CC, 15 LE 17 or HMG alone 18 in ovulatory women undergoing IUI. However, we showed that LE combined with HMG increased the pregnancy and live birth rates in these women.
However, in anovulatory women undergoing IUI, ovarian stimulation is essential. Various stimulation protocols produced similar live birth and pregnancy rates (12.1 and 16%, respectively), both of which rates are significantly higher than those of ovulatory women undergoing IUI without stimulation (7.6 and 9.3%, respectively; both P < 0.01). Moreover, if we compared the outcomes of ovarian stimulation and IUI between anovulatory women and ovulatory women for each stimulation protocol, the pregnancy and live birth rates in anovulatory women were consistently higher, although only the rates for CC and CC combined with HMG were statistically significant (P < 0.01). The overall result suggested that anovulatory women undergoing ovarian stimulation and IUI appeared to have a better prognosis compared with women who were ovulatory.
Taking the above observations together, one can conclude that ovarian stimulation in ovulatory women undergoing IUI appears to have a limited role, with the exception of LE and HMG. It is possible that women who are ovulatory but remain infertile are more likely to have additional or subtle infertility factors compared with those who are anovulatory.
In our series, the overall twin pregnancy rate in women who underwent ovarian stimulation and IUI was 4.9%, which was modestly but not excessively high. In women not receiving ovarian stimulation, the twin pregnancy rate was 0% in our series. It should be noted that the use of LE combined with HMG to produce a modest increase in pregnancy rate to 16.8% was achieved at the expense of a modest increase in the twin pregnancy rate to 6.1%. As for other protocols of ovarian stimulation, including CC, LE, HMG or CC combined with HMG, there was a similar modest increase in the twin pregnancy rate but no increase in pregnancy rate compared with no stimulation. In our study we did not encounter any cases of triplet or higherorder pregnancies among 6302 ovarian stimulation cycles, probably due to gentle HMG stimulation policy adopted in our centre. It has now been recognised that aggressive ovarian stimulation can increase the pregnancy rate, but at the expense of increasing the likelihood of higher-order pregnancy, and that an increasing number of follicles does not increase the pregnancy rate but only leads to a higher risk of multiple pregnancies. 19 Some reports, 20 but not all, 21 have suggested that the miscarriage rate following IUI and ovarian stimulation is higher than for IUI without stimulation. Our series failed to confirm this (20.0% with stimulation versus 14.5% without; P = 0.07). Further studies on this issue are needed.
Finally, the role of IUI in infertility treatment remains controversial. Our study showed that IUI in general, even in a young age group, had an overall pregnancy rate of only about 10%, and a live birth rate of only about 8%. The results are significantly inferior to those achieved with IVF. However, the treatment is simpler and less expensive than IVF. In our view, IUI still has a role in women with infertility.
Conclusion
In ovulatory women undergoing IUI, ovarian stimulation with LE and HMG, but not with CC, LE, HMG or CC combined with HMG, significantly improved the pregnancy and live birth rates. In anovulatory women undergoing ovarian stimulation and IUI, there are no significant differences in pregnancy and live birth rates among the various stimulation protocols.
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